Literature DB >> 8832467

Special issues in the management of gliomas in children with neurofibromatosis 1.

I F Pollack1, J J Mulvihill.   

Abstract

Neurofibromatosis 1 (NF1) is a common multisystem disorder that is frequently associated with neoplastic and non-neoplastic lesions within the central nervous system. Improvements in neuroimaging have led to increased detection of both types of lesions. Focal areas of increased T2 signal represent the most common abnormalities detected. The vast majority of such lesions are non-neoplastic and fluctuate in number and size during childhood. Optic pathway tumors are second in frequency and generally manifest an indolent natural history, although some lesions will increase in size over time and lead to progressive visual impairment. A smaller percentage of patients will develop gliomas within the cerebral and cerebellar hemispheres of brain-stem. This article will review areas of controversy in the evaluation and follow-up of patients with NF1 and will present our approach to these issues. We will also discuss therapeutic considerations in these patients that take into account the unique features of the underlying disorder.

Entities:  

Mesh:

Year:  1996        PMID: 8832467     DOI: 10.1007/bf00250204

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  57 in total

Review 1.  Neurofibromatosis type 1 in childhood.

Authors:  R Listernick; J Charrow
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

2.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

Authors:  T N Basu; D H Gutmann; J A Fletcher; T W Glover; F S Collins; J Downward
Journal:  Nature       Date:  1992-04-23       Impact factor: 49.962

3.  Neurofibromatosis and childhood tumors.

Authors:  J Blatt; R Jaffe; M Deutsch; J C Adkins
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

4.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

Review 5.  Neurofibromatosis and optic pathways gliomas.

Authors:  E M Housepian; T L Chi
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

6.  Neurofibromatosis types 1 and 2: cranial MR findings.

Authors:  S Aoki; A J Barkovich; K Nishimura; B O Kjos; T Machida; P Cogen; M Edwards; D Norman
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

Review 7.  Short- and long-term complications of radiation therapy for pediatric brain tumors.

Authors:  B Donahue
Journal:  Pediatr Neurosurg       Date:  1992       Impact factor: 1.162

8.  Moyamoya phenomenon after radiation for optic glioma.

Authors:  J R Kestle; H J Hoffman; A R Mock
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

9.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

Authors:  R Listernick; J Charrow; M Greenwald; M Mets
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

Review 10.  Neurofibromatosis and central nervous system tumors in childhood.

Authors:  T B Mapstone
Journal:  Neurosurg Clin N Am       Date:  1992-10       Impact factor: 2.509

View more
  4 in total

Review 1.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

2.  Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.

Authors:  E Osztie; P Várallyay; N D Doolittle; C Lacy; G Jones; H S Nickolson; E A Neuwelt
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

3.  Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: case report and literature review.

Authors:  Elpis Mantadakis; Maria Raissaki; Vassiliki Danilatou; Alexander Kambourakis; Eftichia Stiakaki; Maria Kalmanti
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

4.  Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.

Authors:  Sirkku Peltonen; Roope A Kallionpää; Matti Rantanen; Elina Uusitalo; Päivi M Lähteenmäki; Minna Pöyhönen; Janne Pitkäniemi; Juha Peltonen
Journal:  Int J Cancer       Date:  2019-02-18       Impact factor: 7.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.